Stocks and InvestingStocks and Investing
Thu, January 5, 2023
Wed, January 4, 2023
Tue, January 3, 2023
Fri, December 30, 2022

Joshua Schimmer Maintained (TGTX) at Buy with Increased Target to $16 on, Dec 30th, 2022


Published on 2024-10-28 00:42:27 - WOPRAI, Joshua Schimmer
  Print publication without navigation


Joshua Schimmer of Evercore ISI Group, Maintained "TG Therapeutics, Inc." (TGTX) at Buy with Increased Target from $11 to $16 on, Dec 30th, 2022.

Joshua has made no other calls on TGTX in the last 4 months.



There are 2 other peers that have a rating on TGTX. Out of the 2 peers that are also analyzing TGTX, 0 agree with Joshua's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Joshua


  • Alec Stranahan of "B of A Securities" Maintained at Sell with Increased Target to $6 on, Thursday, December 29th, 2022
  • Edward White of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $24 on, Thursday, December 29th, 2022